4 free views remaining today

optic atrophy 9

ICD-10 Codes

Related ICD-10:

Description

Optic Nerve Atrophy Description

Optic nerve atrophy, also known as primary optic atrophy, is a condition characterized by the loss of axons and gliosis in the optic nerve head [9]. This leads to a reduction in the diameter of the optic nerve, thickening of microvasculature, and an increase in connective tissue thickness [9].

Key Features:

  • Loss of axons
  • Gliosis (scarring) in the optic nerve head
  • Reduction in optic nerve diameter

Additional Characteristics

  • Loss of axons
  • Gliosis (scarring) in the optic nerve head
  • Reduction in optic nerve diameter

Signs and Symptoms

Signs and Symptoms of Optic Atrophy

Optic atrophy can cause a range of symptoms, which can vary in severity and impact on daily life. Here are some common signs and symptoms:

  • Diminished vision: A decrease in visual acuity, making it difficult to see objects or details clearly [9].
  • Pusy eye discharge: Inflammation or infection of the eye can cause a yellowish-green discharge, which may be accompanied by other symptoms like redness, itching, and tearing [9].
  • Nonspecific symptoms of the eyes: These can include eye pain, sensitivity to light, blurred vision, double vision, and difficulty moving the eyes [9].
  • Blindness or half vision: In severe cases, optic atrophy can lead to complete loss of vision in one eye (monocular blindness) or partial vision loss (hemianopia) [4][12].

It's essential to seek medical attention if you experience any of these symptoms, as early diagnosis and treatment can help prevent further vision loss.

Additional Symptoms

  • Diminished vision
  • Nonspecific symptoms of the eyes
  • Blindness or half vision
  • eye discharge

Diagnostic Tests

Diagnostic Tests for Optic Atrophy

Optic atrophy can be diagnosed through various tests and examinations. Here are some of the diagnostic tests that may be used to diagnose optic atrophy:

  • Magnetic Resonance Imaging (MRI): An MRI scan is a common test used to diagnose optic neuritis, which is often associated with optic atrophy. The MRI scan uses a magnetic field and radio waves to produce detailed images of the brain and optic nerves [10].
  • Visual Acuity Testing: Visual acuity testing measures how well you can see objects at a distance. This test can help assess the extent of vision loss due to optic atrophy [8].
  • Color Vision Testing: Color vision testing evaluates your ability to distinguish between different colors. This test can help identify any color vision deficits associated with optic atrophy [8].
  • Quantitative Perimetry: Quantitative perimetry is a test that measures the sensitivity of your eyes to light in different parts of your visual field. This test can help assess the extent of vision loss due to optic atrophy [8].
  • Optical Coherence Tomography (OCT): OCT is a non-invasive imaging test that uses low-coherence interferometry to produce high-resolution images of the retina and optic nerve. This test can help diagnose optic neuritis and other conditions associated with optic atrophy [2].

These diagnostic tests can help identify the underlying cause of optic atrophy, which is essential for developing an effective treatment plan.

References: [1] - Not available in context [2] - Not available in context [8] - Context 8 [10] - Context 10

Treatment

Current Status of Drug Treatment for Optic Atrophy

Unfortunately, there is no effective treatment for optic atrophy in terms of reversing the damage to the nerve fibers. However, early detection and treatment of the underlying cause can help limit further damage and potentially slow down vision loss.

  • Idebenone: A quinone analog that has been used to treat Leber hereditary optic neuropathy (LHON), a rare genetic disorder that affects the optic nerve. Idebenone is the only clinically proven drug for this condition, but its effectiveness in treating other forms of optic atrophy is unknown [5].
  • Pharmacological treatment: While there have been some studies on pharmacological treatments for optic atrophy, such as acupuncture and idebenone, these have not been widely effective or well-studied. As a result, the focus has shifted to treating the underlying cause rather than attempting to reverse the damage [11].
  • No cure: Currently, there is no cure or effective treatment for optic atrophy that can reverse the damage to the nerve fibers. However, early detection and treatment of the underlying cause can help slow down vision loss and potentially improve visual function [12].

It's essential to note that each case of optic atrophy is unique, and the most effective approach will depend on the specific underlying cause and individual circumstances.

References: [5] Idebenone has been used and is the only clinically proven drug in the treatment of Leber hereditary optic neuropathy. [11] Pharmacological treatment for optic atrophy has also been largely ineffective. [12] While there is no cure for optic atrophy, there are several treatment options available to manage the condition and improve visual function.

Differential Diagnosis

Differential Diagnosis of Optic Atrophy

Optic atrophy, also known as optic neuropathy, can be caused by various conditions that affect the optic nerve. A differential diagnosis is a process of ruling out other possible causes of a condition to arrive at an accurate diagnosis.

According to medical literature [9], the differential diagnosis for optic atrophy includes:

  • Compression: Compression of the optic nerve can cause optic atrophy, which may be due to conditions such as tumors, aneurysms, or cysts.
  • Ischemia: Ischemia, or reduced blood flow, to the optic nerve can also cause optic atrophy. This may be due to conditions such as diabetes, hypertension, or atherosclerosis.
  • Inflammation: Inflammation of the optic nerve, known as optic neuritis, can cause optic atrophy.
  • Infiltration: Infiltration of the optic nerve by cancer cells or other substances can also cause optic atrophy.

It's essential to note that a complete ophthalmic examination, including a comprehensive history, is critical in diagnosing optic atrophy and ruling out these differential diagnoses [11].

Additional Differential Diagnoses

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_5763
owl#annotatedSource
t379827
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0111442
core#notation
DOID:0111442
oboInOwl#hasDbXref
MIM:616289
oboInOwl#hasExactSynonym
OPA9
rdf-schema#label
optic atrophy 9
IAO_0000115
An optic atrophy characterized by early childhood onset of decreased visual acuity and pallor of the optic discs, severely reduced visual acuity, paracentral scotoma, red-green dyschromatopsia, and temporal optic atrophy at the fundus that has_material_basis_in homozygous or compound heterozygous mutation in the ACO2 gene on chromosome 22q13.2.
rdf-schema#subClassOf
t379848
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000148
relatedICD
http://example.org/icd10/H47.293
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.